Antimicrobial Resistance Surveillance Dashboard

Bacterial and fungal pathogens cause urinary tract infections, skin and soft tissue infections, pneumonia, bloodstream infection and meningitis, amongst other types of infections. These can range from mild infections which can be treated as outpatients to severe, life-threatening infections which require hospitalization.

Over time, bacterial and fungal pathogens evolve and develop resistance to existing antimicrobial agents. Well known drivers of antimicrobial resistance include inappropriate use of antimicrobials in humans and animals and prolonged duration of antimicrobial therapy.

Antimicrobial resistance is a critical public health threat. Limited antimicrobial treatment options have resulted in increased morbidity and mortality from previously treatable infections. This is especially true of severe infections in the hospital (both community- acquired infections and healthcare associated infections). Pathogens of concern include the ESKAPE organisms – Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp and fungal pathogens, including a number of Candida species such as Candida auris and Aspergillus species.

To combat AMR, surveillance of pathogens and their evolving resistance profiles is required. Surveillance allows for implementation of appropriate infection prevention and control measures and updating of empiric treatment recommendations based on analysis of pathogen – specific antimicrobial susceptibility data.

Explore our comprehensive Antimicrobial Resistance (AMR) Dashboard, providing real-time data and insights to track bacterial and fungal antimicrobial resistance in both the public and private healthcare sectors.